Evolve Your Success

JANUARY 23, 2024

In the changing balance between innovation and tradition, medical sales succeeds with personal connection, persistence, and the commitment to link technology and patient care. For today’s episode, we have Edouard Saget to discuss the big question: Will AI replace medical sales workforce and surgeons? Tune in to find out!

Medical sales 52

Medical sales Sales Medical Physicians 52

Evolve Your Success

FEBRUARY 6, 2024

Mark Copeland joins Samuel Adeyinka to share his medical sales experience in sterile processing and infection prevention. He also talks about partnering with small businesses and how they are leading the competition in this particular space. How big is your sales team? Who in medical sales is a thing of heart?

Medical sales 59

Medical sales Medical Sales Doctors 59

Pharmaceutical Technology

OCTOBER 5, 2022

Between 2009 and 2014, the time period of Biogen’s alleged misconduct, the standard of care for MS involved the use of Biogen’s immunomodulatory drugs such as Avonex (Interferon beta-1a), Tecfidera (dimethyl fumarate), and Tysabri (natalizumab). More recently, Biogen has been facing competition from dimethyl fumarate generics.

Government 59

Government Specialization Physicians Education 59

pharmaphorum

JANUARY 24, 2023

A just-published report from the Medicines Manufacturing Industry Partnership (MMIP) – set up by the UK government and biopharma industry in 2014 to drive growth in the category – says the sector has the potential to be a driver for the UK economy in the next decade.

Manufacturing 107

Manufacturing Medicine Government Pharmaceutical manufacturing 107

pharmaphorum

SEPTEMBER 11, 2022

Analysts at Mizuho have suggested that competition from BMS’ drug could trim Otezla’s 2025 sales from $3 billion to $2 billion, although Amgen is attempting to defend its product by expanded the label of the drug to include mild psoriasis. It had been approved since 2014 for moderate to severe cases only.

FDA 52

FDA Marketing Sales Patients 52

pharmaphorum

NOVEMBER 17, 2022

The 2019 VPAS , just like its predecessor that was in place from 2014, has at its heart a payback mechanism. The DHSC said that this was an exceptional change, reflecting the rapid growth in sales in 2021 driven in part by COVID-19. Initial forecast growth rate of measured sales. Actual growth rate of measured sales.

Government 96

Government Sales Medicine Consulting 96

pharmaphorum

JANUARY 16, 2023

Since 2014, the repayment percentage detailed in the VPAS and predecessor the PPRS averaged at around 7%, but skyrocketed to 19% in 2022 ahead of a government-agreed cap at 15%, and rose again to 26.5% in 2022. . ” The post AbbVie, Lilly pull out of UK voluntary drug pricing agreement appeared first on.

Government 69

Government Medicine Consulting Management 69

pharmaphorum

JANUARY 27, 2023

There is global capital out there for us to attract, as well as finance in the City of London [that] we need to unlock, but competition is fierce.” Bates continued: “We expected a fall in investment following two bumper years, but it should still be considered a warning.

Pharma 52

Pharma Manufacturing Medicine Biopharma 52

The Brooks Group

OCTOBER 3, 2017

Sales managers must prepare their salespeople for approaching these complex buying environments with confidence, and that starts with understanding the roles that exist within a buying committee. in late 2014. A demonstration of your product or service over the competition would help convince this type of buyer.

Sales 49

Sales Sales Management Competition Management 49

Cesare Ferrari

OCTOBER 8, 2022

He had improved sales by tweaking the drink’s flavor slightly, and so was receptive to the idea that changing the flavor of Coke could boost profits. The Fire Phone was launched in Seattle on June 18, 2014 , at a press event held by Amazon’s CEO, Jeff Bezos. Amazon’s Fire Phone. What went wrong?

Management 52

Management Marketing Medical Sales 52

Cadensee

JULY 26, 2021

Until back in 2014, I met the team at Schneider Children's Medical Center of Israel. We established a wholly owned subsidiary in the US and we have an office in San Diego with sales and marketing personnel. Which oftentimes, the sales are running very fast and the operations isn't there to support it. It's wonderful.

Retail 52

Retail Marketing Doctors Food 52

Pharmaceutical Technology

APRIL 20, 2023

In 2022, Otezla made up for 9% of Amgen’s total product sales, having sold over $2.2 This is one of several patent infringement cases Amgen has pursued in recent years to stave competition. Despite this legal win, Amgen still faces a competitive psoriasis market as other drugs enter the landscape. Patent No.

Competition 52

Competition Marketing FDA Prospecting 52

Pharmaceutical Technology

JANUARY 6, 2023

The agreement outlined that Par would keep its generic equivalent off the market for as many as two years, delaying the generic launch till September 30, 2014. In a press release, the company said a generic launch would damage sales in FY 2023 by $300,000. These actions allegedly led to the extension of Novartis’ patents.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97

Pharmaceutical Technology

JUNE 21, 2023

The FDA first approved Jardiance to help control blood sugar in adults with T2D in 2014. from Jardiance’s sales in 2022 while Boehringer Ingelheim made Synjardy sales amounting to €5.83bn ($6.37bn). This is the first time the FDA has approved an oral diabetes drug for paediatric patients since its approval of metformin in 2000.

Medicine 59

Medicine FDA Food and Drug Administration Sales 59

Pharmaceutical Technology

MAY 26, 2023

The US Food and Drug Administration (FDA commissioner Dr. Robert Califf says, “The illegal sale of prescription drug stimulants online puts Americans at risk and contributes to potential abuse, misuse, and overdose.” In 2014, the US National Association of Boards of Pharmacy (NABP) launched the “.pharmacy”

Food and Drug Administration 52

Food and Drug Administration Prescription FDA Medical 52

Pharmaceutical Technology

NOVEMBER 30, 2022

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. million in Q3.

Medical 105

Medical Manufacturing Insurance Side effects 105

Pharmaceutical Technology

NOVEMBER 30, 2022

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. million in Q3.

Medical 98

Medical Manufacturing Insurance Side effects 98